IRIS Institutional Research Information System - OPENBS Open Archive UniBS

COLLO, LUIGIA RINALDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.306
AS - Asia 3.035
EU - Europa 2.787
SA - Sud America 601
AF - Africa 68
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 9
Totale 11.819
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.220
SG - Singapore 1.102
CN - Cina 1.070
PL - Polonia 676
UA - Ucraina 599
BR - Brasile 497
IT - Italia 340
DE - Germania 288
HK - Hong Kong 277
VN - Vietnam 206
FR - Francia 198
FI - Finlandia 190
GB - Regno Unito 148
TR - Turchia 103
RU - Federazione Russa 94
IE - Irlanda 93
IN - India 93
CA - Canada 45
AR - Argentina 43
CH - Svizzera 37
BD - Bangladesh 33
BE - Belgio 27
ID - Indonesia 26
MX - Messico 23
IQ - Iraq 22
NL - Olanda 21
EC - Ecuador 20
NG - Nigeria 20
AT - Austria 19
IR - Iran 16
ZA - Sudafrica 15
CZ - Repubblica Ceca 14
AU - Australia 12
ES - Italia 12
SE - Svezia 12
JP - Giappone 11
MA - Marocco 11
CL - Cile 10
EU - Europa 9
KZ - Kazakistan 9
SA - Arabia Saudita 9
CO - Colombia 8
PE - Perù 8
VE - Venezuela 8
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
JO - Giordania 6
CR - Costa Rica 5
EG - Egitto 5
ET - Etiopia 5
PA - Panama 5
PK - Pakistan 5
DZ - Algeria 4
KE - Kenya 4
KR - Corea 4
OM - Oman 4
LB - Libano 3
LT - Lituania 3
BH - Bahrain 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
KG - Kirghizistan 2
LU - Lussemburgo 2
MY - Malesia 2
NP - Nepal 2
PT - Portogallo 2
PY - Paraguay 2
TM - Turkmenistan 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
JM - Giamaica 1
KI - Kiribati 1
LV - Lettonia 1
MD - Moldavia 1
PH - Filippine 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 11.819
Salva come PNG Salva come JPEG
Città #
Warsaw 675
Singapore 630
Woodbridge 481
Ashburn 467
Fairfield 463
Jacksonville 436
Houston 285
Hong Kong 273
Ann Arbor 240
Cambridge 231
Beijing 229
Chandler 229
Seattle 201
The Dalles 195
San Jose 190
Princeton 177
Wilmington 175
Nanjing 139
New York 123
Brescia 101
Dearborn 98
Lauterbourg 95
Helsinki 93
Dublin 92
Istanbul 85
Los Angeles 73
Des Moines 67
Ho Chi Minh City 65
Nanchang 54
Munich 51
Buffalo 49
São Paulo 48
Hanoi 39
Milan 39
Moscow 38
Hebei 37
Jiaxing 37
Shenyang 37
Basel 35
Council Bluffs 35
Dong Ket 34
Changsha 32
Dallas 28
Tianjin 28
London 27
Shanghai 27
Jinan 26
San Francisco 26
Santa Clara 26
Orem 25
Brussels 24
San Donà Di Piave 24
Rio de Janeiro 23
Chicago 21
San Diego 21
Abuja 20
Turku 20
Redondo Beach 19
Jakarta 18
Toronto 17
Pune 16
Brooklyn 15
Lancaster 15
Leawood 15
Montreal 15
Hangzhou 14
Hefei 14
Kunming 14
Rome 13
San Mateo 13
Boston 12
Brno 12
Frankfurt am Main 12
Guangzhou 12
Zhengzhou 12
Atlanta 11
Boardman 11
Denver 11
Phoenix 11
Teramo 11
Guayaquil 10
Lanzhou 10
Manchester 10
Ningbo 10
Tokyo 10
Brasília 9
Haiphong 9
Johannesburg 9
Mexico City 9
Norwalk 9
Taizhou 9
Vienna 9
Ardabil 8
Augusta 8
Baghdad 8
Belo Horizonte 8
Changchun 8
Charlotte 8
Chennai 8
Curitiba 8
Totale 8.029
Salva come PNG Salva come JPEG
Nome #
Ropinirole and Pramipexole Promote Structural Plasticity in Human iPSC-Derived Dopaminergic Neurons via BDNF and mTOR Signaling 320
Redistribution of DAT/α-synuclein complexes visualized by “in situ” proximity ligation assay in transgenic mice modelling early Parkinson’s disease 311
Pre-synaptic dopamine D(3) receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways 262
Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine d3 receptors and akt-mtorc1 signaling 253
Ketamine enhances structural plasticity in human dopaminergic neurons: Possible relevance for treatment-resistant depression 221
Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation 192
Cloning of P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels 177
Pluripotent Stem Cell Based Cultures to Study Key Aspects of Human Cerebral Cortex Development 174
Structural plasticity induced by ketamine in human dopaminergic neurons as mechanism relevant for Treatment-Resistant Depression 169
(2 R,6 R)-Hydroxynorketamine promotes dendrite outgrowth in human inducible pluripotent stem cell-derived neurons through AMPA receptor with timing and exposure compatible with ketamine infusion pharmacokinetics in humans 168
Derivation of midbrain dopaminergic neurons from human inducible pluripotent stem cells to model neurological disorders. 163
Structural plasticity in mesencephalic dopaminergic neurons produced by drugs of abuse: critical role of BDNF and dopamine 162
The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons 160
A human translational model based on neuroplasticity for pharmacological agents potentially effective in Treatment-Resistant Depression: Focus on dopaminergic system 160
Ketamine increases the expression of GluR1 and GluR2 α-amino-3-hydroxy-5-methy-4-isoxazole propionate receptor subunits in human dopaminergic neurons differentiated from induced pluripotent stem cells 155
An antagonist-insensitive P2X receptor expressed in epithelia and brain 149
ATP mediated cytotoxicity in microglial cells. 146
Distictive functions of a6b4 and other integrins in epithelial cells. 144
P2X1 receptor activation in HL60 cells. 144
Blockade of human P2X7 receptor function with a monoclonal antibody. 144
Ketamine enhances structural plasticity in mouse mesencephalic and human iPSC-derived dopaminergic neurons via AMPAR-driven BDNF and mTOR signaling 143
Pharmacological targeting of dopamine D3 receptors: Possible clinical applications of selective drugs. 142
A direct interaction between dopamine D1 receptor and phosphatase Shp-2 triggers Erk activation in striatal neurons 138
Ketamine effects on mammalian target of rapamycin signaling in the mouse limbic system depend on functional dopamine D3 receptors 138
Purinoceptors in the central nervous system 135
The NMDA/D1 receptor complex as a new target in drug development 132
Critical role of dopamine D3 receptor in structural plasticity generated by exposure to drugs of addiction in mesencephalic dopaminergic neurons 132
Dopamine D3 receptors are critically involved in the neurotrophic effects of cocaine and nicotine on the mouse mesencephalic dopaminergic neurons 130
The tyrosine phosphatase Shp-2 interacts with the dopamine D(1) receptor and triggers D(1) -mediated Erk signaling in striatal neurons. 129
Genetic variation in CHRNA7 and CHRFAM7A is associated with nicotine dependence and response to varenicline treatment 128
The neurobiology of dopamine receptors: evolution from the dual concept to heterodimer complexes 127
Tissue distribution of the P2X7 receptor 126
Alpha-synuclein aggregation in dopaminergic cells is modulated by glucose metabolism 126
In-vivo silencing of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of Parkinson’s disease 125
A new isoform of the laminin receptor α7β1 is developmentally regulated in skeletal muscle. 124
Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation. 123
D3 receptor involvement in neurotrophic effects of amphetamine and cocaine on mesencephalic dopaminergic neurons 123
Alphα6-containing nicotinic acetylcholine receptors mediate nicotine-induced structural plasticity in mouse and human iPSC-derived dopaminergic neurons 122
Attenuated acute effects of ketamine on mTOR pathway in the limbic system of dopamine D3 receptor knock-out mice 120
Immature neuronal phenotype derived from mouse skin precursor cells differentiated in vitro. 119
Dopamine D3 receptor and beta-2 containing nicotinic acetylcholine receptor are critical in mediating nicotine effects on dopaminergic neurons morphology 118
P2X receptors: an emerging channel family. 117
Differential onset of expression of alpha7 and beta1D integrins during mouse heart and skeletal muscle development. 116
Neuroadaptation mechanisms to nicotine in mesencephalic dopaminergic neurons: role of dopamine D3 receptor and nicotinic acetylcholine receptors. 116
CRISPR targeting of human induced pluripotent stem cells (HIPSCS) for lineage tracing of HIPSCS-derived neural stem cells during cortical development in vitro 115
Cell-type specific integrin variants with alternative α chain cytoplasmic domain 114
Morphogenetic changes produced by cocaine and nicotine in mesencephalic dopaminergic neurons: role of dopamine D3 receptor 114
Knock-down of the tyrosine phosphatase Shp-2 ameliorates L-DOPA-induced dyskinesia in a rat model of parkinson's disease. 114
Ketamine produces structural plasticity in dopaminergic neurons via co-activation of MEK-ERK and Akt-mTOR pathways: translation from mouse primary culture to human iPSC-derived neurons 114
Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential 114
Dopamine D1R activation triggers Erk1/2 activation in striatal neurons through the interaction with the protein tyrosine phosphatase Shp-2. 112
Role of dopamine D1 receptor and phosphatase Shp-2 in L-DOPA-induced dyskinesia in a rat model of Parkinson's disease. 112
Neurotrophic effects of cocaine on mouse mesencephalic dopaminergic neurons are mediated by dopamine D3 receptors 111
Dopamine-induced Erk activation in striatal neurons is mediated by a direct interaction between the D1 receptor and the tyrosine phosphatase Shp-2. 110
Molecular mechanisms underlying dopamine D1R-dependent activation of striatal Erk1/2 in L-DOPA induced dyskinesia in a rat model of Parkinson’s disease. 109
The Shp-2 tyrosine phosphatase interacts with the dopamine D1 receptor and triggers D1-mediated Erk signalling in striatal neurons. 108
Dopamine D1R activation modulates intracellular signalling and triggers Erk1/2 activation in striatal neurons through the interaction with the protein tyrosine phosphatase Shp-2. 108
Ketamine produces structural plasticity in dopaminergic neurons in vitro via co-activation of MEK-ERK and Akt-mTOR pathways: role of BDNF and dopamine D3 receptor 108
Spontaneous cell fusion in macrophage cultures expressing high levels of the P2Z/P2X7 receptor. 107
Dopamine agonists produce neurotrophic effects on mesencephalic dopaminergic neurons via dopamine D3 receptor activation 107
Nicotine produces structural plasticity of mesencephalic dopaminergic neurons via activation of Akt-mTor pathway 107
Selective dopaminergic alpha-synuclein pathological changes following glucose deprivation "in vitro": implications for Parkinson's disease 106
Ketamine produces structural plasticity of mouse mesencephalic dopaminergic neurons via activation of Akt-mTOR pathway: role of dopamine D3 receptor. 106
Glimpse into cell reprogramming: emerging role of progesterone receptor in priming potency of induced pluripotent stem cells (iPSCs). 103
Effetti neurotrofici dei farmaci agonisti preferenziali D3 sui neuroni mesencefalici: implicazioni terapeutiche per la malattia di Parkinson. 103
Oxide Nanowires for Neuron Adhesion and Growth 102
Nicotine enhances the neuroplasticity of dopamine neurons: role of dopamine D3 receptors and acetylcholine nicotinic receptors. 101
Human iPS cell-derived dopaminergic neurons reveal role for D3 receptors and mTOR in induction of structural plasticity by antiparkinson DA agonists 100
The integrin alpha6beta4 in epithelial and carcinoma cells 98
Testing drugs for structural plasticity in dopaminergic neurons: translation from mouse primary cell culture to human iPSC-derived neurons 97
Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques 97
Distinct alpha7A-beta1 and alpha7B-beta1 integrin expression patterns during mouse development: alpha7A is restricted to skeletal muscle but alpha7B is expressed in striated muscle, vasculature, and nervous system. 96
Testing the effect of dopamine agonists and of drugs of addiction on structural plasticity of dopaminergic neurons: translation from mouse primary cell culture to human iPSC-derived neurons 96
Evidence for soluble Interleukin-2 receptor (IL-2) as immunosuppressive factor. 94
Glimpse into cell reprogramming: emerging role of progesterone receptor in priming potency of induced pluripotent stem cells (iPSCs) 90
Gradient of integrin α6A expession in the myocardium during early heart development. 90
Nicotine enhances structural plasticity in mesencephalic dopaminergic neurons: involvement of dopamine D3 receptors and nicotinic acetylcholine receptors. 89
Long-term expansion of dopaminergic progenitors from human induced pluripotent stem cells (iPSCs) and differentiation into dopaminergic neurons in vitro and in vivo 89
Involvement of nicotinic acetylcholine receptors and dopamine D3 receptors in structural plasticity of dopaminergic neurons 88
Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings 88
Loss of Synaptic D1 Dopamine/N-Methyl-D-aspartate Glutamate Receptor Complexes in L-DOPA-Induced Dyskinesia in the Rat. 87
Endothelial cell integrin alpha5beta1 expression is modulated by cytokines and during migration in vitro. 85
Neuroprotective effects of D2/D3 agonists in an "in vitro" model of dopaminergic degeneration 84
Myogenic conversion of NIH3T3 cells by exogenous MyoD family members: dissociation of terminal differentiation from myotube formation. 83
Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation. 83
Dopamine D3 receptors mediate the neurotrophic effects of dopaminergic agonists on mesencephalic dopaminergic neurons. 81
Dopamine D3 receptors mediate the neurotrophic effects of dopaminergic agonists on mesencephalic dopaminergic neurons 80
Meccanismo molecolari e cellulari nel Morbo di Parkinson 78
Glimpse into cell reprogramming: emerging role of progesterone receptor in priming potency of induced pluripotent stem cells (iPSCs). 77
The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA. 77
Downregulation of dopamine D1/NMDA receptor complexes in the post synaptic densities of dyskinetic rats 75
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs) 73
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs) 72
Nicotine produces neurotrophic effects on mesencephalic dopaminergic neurons: role of dopamine D3 receptors and nicotinic acetylcholine receptors 70
Pharmacology profile of F17464, a dopamine D3 receptor preferential antagonist 67
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs) 66
Involvement of DA D3 Receptors in Structural Neuroplasticity of Selected Limbic Brain Circuits: Possible Role in Treatment-Resistant Depression 63
Glimpse into cell reprogramming: emerging role of progesterone receptor in priming potency of induced pluripotent stem cells (iPSCs) 63
Progesterone receptor is constitutively expressed in induced Pluripotent Stem Cells (iPSCs) 57
Cortisol-dependent impairment of dendrite plasticity in human dopaminergic neurons derived from hiPSCs is restored by ketamine: Relevance for major depressive disorders 55
Totale 12.016
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.923
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.923
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021367 0 0 0 0 0 0 0 0 0 121 189 57
2021/2022667 62 140 4 18 9 19 30 43 30 75 54 183
2022/2023627 93 3 10 54 57 187 4 64 106 0 15 34
2023/2024651 41 10 52 53 32 147 28 23 131 17 14 103
2024/20251.762 2 40 24 253 157 118 135 35 240 165 367 226
2025/20263.021 320 433 214 411 307 186 588 159 189 214 0 0
Totale 12.195